Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Clinical trial NCT07391774 · RECRUITING

Trial details

NCT number: NCT07391774
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Estrogen Receptor-Positive Breast Carcinoma HER2-Negative Breast Carcinoma

Start date: 2026-08-10
Primary completion: 2029-07-31
Enrollment: 1978

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.